INTRODUCTION
For many years, veterinary diagnostic microbiology had been considered a subspecialty within clinical microbiology. This seemed quite logical as many of the pathogens affecting animals are similar to human pathogens and the same basic isolation techniques are employed in both fields. Moreover, the role of veterinary diagnostic microbiologists is similar to that of clinical microbiologists in that their primary responsibility is to provide clinically relevant information to the veterinarian concerning the causative agent of a disease and, when possible, the antimicrobial susceptibility profile of that agent. In recent years, however, it has become apparent that many veterinary pathogens are substantially different from human pathogens and require unique methods for identification and antimicrobial susceptibility testing (12, 82, 85, 103, 106. 107, 115) .
The primary difference between clinical microbiology laboratories for human and veterinary pathogens is that the clinical laboratory for humarL receives isolates from one host species while the veterinary microbiology laboratory may receive isolates from six major host species and several minor species (12, 35) . Generally, the major veterinary species can be divided into companion, food-producing, and exotic animals. The major companion animal species include dogs, cats, and horses, while the major food-producing animals include cattle, swine, sheep, and poultry (chickens and turkeys). Exotic animals include, but are not limited to, reptiles, camelids (llamas and alpacas), ornamental birds (parakeets and cockatiels), ornamental fishes, and zoo animals (land and aquatic). Additionally, aquaculture of fresh-and saltwater fish is rapidly becoming a major economic market and presents a unique set of challenges to the veterinary microbiologist in terms of pathogen identification and interpretation of antimicrobial susceptibility test results.
The type and management of the animal may also impact how laboratory results are utilized. For on the identification and antimicrobial susceptibility of an isolate from companion animals such as dogs will be used to select treatment for that individual animal, whereas the same information for an isolate from a pig might be used to devise treatment (or control measures) for the entire herd. Furthermore, the veterinary microbiologist must also be aware of the consequences of antimicrobial therapy in food-producing animals in terms of efficacy, toxicities, and residue avoidance. Thus, the veterinary microbiologist must be familiar with the clinical and economic significance of pathogens isolated from the various host species and must accurately interpret and report the antimicrobial susceptibilities of those isolates. The purpose of this paper is to review the accuracy of commercial identification systems in identifying bacterial pathogens isolated from various animal species and to consider the problems associated with antimicrobial susceptibility tests (ASTs) in veterinary medicine. IDENTIFICATION Identification of veterinary pathogens by conventional methods is tedious and time-consuming (12, 17) . Commercial identification systems are widely used by clinical microbiologists as convenient, cost-effective alternatives to conventional methods. However, many of these systems incorporate a limited number of veterinary strains in their data base which may limit the accuracy of the system for identification of veterinary pathogens (27, 59, 60, 85, 97, 102, 104, 105, (111) (112) (113) . A review of the commercial systems that have been evaluated with veterinary pathogens follows.
Staphylococci
In recent years, the number of described species within the genus Staphylococcus has increased dramatically (reviewed in references 55 and 106) . Many of these new species have been isolated from animals (Table 1) (21, 23, 25, 40-42, 47, 89-91, (59) determined that the Staph-ldent system identified only 54 .0% of staphylococci (41.8% of non-S. aurelis isolates) isolated from the bovine udder. The primary reason for the poor accuracy was the inability of the system to distinguish Staphylococcus epidermidis from S. hyicus. Similarly, Jasper et al. (50) found that the Staph-Ident system could identify only 23 of 323 (7.1%) non-S. aureus isolates from bovine mammary glands; the misidentification of S. hyicus was the primary reason for poor accuracy. Rather et al. (84) determined that the Staph-Ident system identified only 45 (107) determined that the Staph-Trac system could identify only 66.1% of staphylococci isolated from bovine mammary glands. Misidentification of S. hyiculs as Staphlylococcus sirnulans due to negative phosphatase tests was the primary reason for the poor performance of the system. Furthermore, the Staph-Trac system could not differentiate S. intemnedius from S. aureus (107) . Recently, the Staph-Trac data base has been updated to permit the differentiation of S. intermedius from S. alureus on the basis of mannitol and maltose utilization.
The API 20GP system (bioMerieux-Vitek) consists of 20 microcupules containing dehydrated substrates for the identification of staphylococci and group D streptococci (112) . The first 10 tests are identical to the Staph-Ident system, while the second 10 tests were selected from the API 20S (bioM6rieux-Vitek) streptococcal identification system. This system was evaluated to determine if the second 10 tests improved the accuracy of the Staph-Ident system (112) . Although the system correctly identified 90.2% of S. aureus strains, overall accuracy was placed at 56.1%. Unfortunately, this system also had difficulty differentiating S. hyicus from S. epidermidis. Poor performance was attributed to the limited number of veterinary strains in the data base.
The Minitek Gram-Positive Set (BBL Microbiology Systems, Cockeysville, Md.) is a 20-test system based on substrateimpregnated paper disks (11 1) . This system was evaluated with 130 staphylococci isolated from the bovine mammary gland with initial accuracy placed at 79.2%. However, modification of the system to correct for data base deficiencies improved accuracy to 87.7% (1 11) .
The Staph-Zym system (Rosco Diagnostica, Taastrup, Denmark) consists of 10 enzymatic tests in minitubes in a rigid, transparent, plastic cartridge (57, 114) . Lammler (57) determined that the Staph-Zym system correctly identified all strains of S. hyiclus isolated from cattle and swine and S. intermedius from dogs. An evaluation (114) all veterinary staphylococci, and many of the newly described species either cannot be identified by currently available systems or will be misidentified. In these situations, the veterinary microbiologist should be familiar with the limitations of the system, which may necessitate the use of conventional test schemes for final identification (26) .
Streptococci
The streptococci are isolated from a variety of animal diseases. Streptococcus agalactiae (group B), Streptococcus dysgalactiae (includes strains previously designated "S. equisimilis") (group C), Streptococcus equi subsp. equi ("S. equi") (group C), Streptococcus equi subsp. zooepidemicus ("S. zooepidemicus") (group C), Streptococcus porcinus (group E), and Streptococcus canis (group G) are the most frequently encountered beta-hemolytic streptococci (14, 24, 31, 33, 106) ; group A streptococci (Streptococcus pyogenes) are only rarely isolated from animal specimens (106) . Viridans streptococci frequently isolated from animal diseases include Streptococcus equinus ("S. bovis"), Streptococcus suis, and Streptococcus uberis; alphahemolytic strains of Enterococcus spp. are also encountered (32, 54, 103, 106) . A list of the various disease processes and hosts for the streptococcal and enterococcal species is presented in Table 2 . Thus, a system for identification of streptococci isolated from veterinary sources must be able to differentiate the beta-hemolytic streptococci to the species level as well as a diverse group of viridans streptococci.
Commercially available Lancefield grouping tests are useful for rapid, confirmatory identification of beta-hemolytic streptococci. Saxegaard (88) (80) determined that this system identified 71.4% of 84 isolates. However, the system had difficulty identifying strains of S. uberis and S. bovis, and these workers concluded that an improved data base was needed to optimize identification of mastitis-producing streptococci. A subsequent study (104) In conclusion, only the Rapid Strep system has been found to accurately identify streptococci isolated from a wide range of animal diseases. The remaining systems have been evaluated with streptococci isolated from bovine mastitis but not other animal diseases. Thus, these systems should not be relied upon as a primary method of identifying streptococci from other animal diseases until properly evaluated.
Gram-Negative Bacilli
The gram-negative bacilli isolated from veterinary sources can generally be categorized into two groups: (i) organisms common to both humans and animals, including the enteric bacilli such as Eschenichia coli, Salmonella spp., and glucose nonfermenters such as Pseudomonas spp.; and (ii) veterinaryspecific organisms such as Pasteurella haemolytica, Haemophilus somnus, and Actinobacillus pleuropneumoniae (12) . Thus, a system with a robust data base may perform well with the former group but fail to provide acceptable accuracy with the latter.
Swanson and Collins (95) compared the API 20E system (bioMerieux-Vitek) with conventional methods for identification of veterinary members of the Enterobacteniaceae family and obtained an overall accuracy level of 96.0%. When this system was evaluated with nonenteric isolates (Pasteurella multocida, P. haemolytica, and Actinobacillus spp.), the overall accuracy was reduced to 62.0% (15) . In another study (16) , the ability of the API 20E, Minitek, and Oxi/Ferm (Roche Diagnostics, Nutley, N.J.) systems to identify P. multocida and P. haemolytica was determined. None of the systems tested provide acceptable levels of identification; accuracy levels were 64.0, 64.0, and 76.0% for the API 20E, Minitek, and Oxi/Ferm systems, respectively. However, the Oxi/Ferm system provided a category but not a specific identification. More recently, Salmon et al. (85) evaluated the RapID NH system, a 4-h system designed for identification of Haemophilus and Neisseria spp. isolated from humans, with isolates of H. somnus, P. multocida, and P. haemolytica from bovine respiratory disease and A. pleuropneumoniae isolated from swine respiratory disease. These workers (85) determined that minor modification of the data base to include H. somnus strains and to include isolate source would permit identification of these important veterinary pathogens.
Only limited evaluations of automated systems with gramnegative veterinary pathogens are available. The Quantum II system (Abbott Laboratories, Irving, Tex.), an automated system that is no longer available, was evaluated for its ability to identify enteric and nonenteric gram-negative veterinary pathogens (53, 97 (3) determined that this system correctly identified 81.4% of 183 strains representing eight genera to the genus level and 59.6% to the species level. Misidentifications with the RapID ANA resulted from misassignment of veterinary species not in the data base to a human-associated species in the data base.
Two studies (27, 39) have examined the ability of the API Coryne system (bioMerieux-Vitek) to identify strains of A.
pyogenes. Ding and Lammler (27) determined that 36 of 42 A. pyogenes strains were correctly identified with the API Coryne system, with the remaining six strains yielding unlisted profile numbers. These workers concluded that while the system facilitated identification of A. pyogenes, an improved data base was needed to enhance accuracy. In contrast, Guerin-Faublee et al. (39) determined that the API Coryne system could identify only 58 of 103 A. pyogenes isolates and that the system should be reevaluated before use in veterinary diagnostic laboratories. Morrison and Tillotson (67) determined that strains of A. pyogenes yielded unique profile numbers with the Rapid Strep system and that this system could be used to accurately identify this organism. This would be particularly useful in mastitis bacteriology laboratories, because A. pyogenes is frequently isolated from bovine mammary glands and the Rapid Strep system is widely employed for identification of streptococci isolated from bovine mastitis.
Serpulina hyodysenteriae ("Treponema hyodysenteniae"), an anaerobic spirochete, is the causative agent of swine dysentery and can be difficult to differentiate from the nonpathogenic organism, Serpulina innocens (2, 93). Achacha and Messier (2) used the RapID ANA II (Innovative Diagnostics) and the ANI card (bioMerieux-Vitek) to identify isolates of S. hyodysenteniae and S. innocens. With the ANI card, ,-galactosidase was the only test that differentiated the two species; with the RapID ANA II system, both the a-galactosidase and the indole tests could be used to differentiate the two organisms. While these workers concluded that both systems could be used to differentiate S. hyodysenteriae from S. innocens, the RapID ANA II was considered easier to use. In summary, it appears that the accuracy of commercial identification systems with veterinary pathogens varies widely. The greatest single factor impacting the accuracy of the systems appears to be the number of veterinary strains incorporated into the data base. Additionally, differences in the distribution of bacterial species between various host animals may influence the choice of system. For example, the StaphIdent system may be preferred for use in diagnostic laboratories receiving predominately canine isolates because this sys- Table 3 . When none of the compounds approved for use in that host animal offers sufficient activity against the pathogen, (1, 71, 82) . While the data necessary to establish these performance characteristics are well defined in human medicine (1, 71) (77, 92) . This organism requires media supplemented with NADH for growth (77, 92) . Past studies on the in vitro susceptibility of A. pleuropneumoniae have used Mueller-Hinton agar (34) , Mueller-Hinton broth (61), Iso-Sensitest agar (65) , Iso-Sensitest broth (28), tryptone yeast extract broth (34) , and brain heart infusion broth (29) . All media in these studies were supplemented with NADH in concentrations ranging from 0.001 to 0.05%. Additionally, many veterinary diagnostic laboratories now use the Haemophilus Test Medium recommended by NCCLS for susceptibility testing of Haemophilus influenzae (69, 70) for testing A. pleuropneumoniae (101) . It appears that additional studies are needed to determine which medium and NADH supplementation level provide acceptable performance characteristics for susceptibility testing of A. pleuropneumoniae. Additionally, a quality control strain of A. pleuropneumoniae needs to be identified for routine testing.
Staphylococcus hyicus is frequently isolated from bovine mammary glands and is the etiological agent of exudative dermatitis in pigs (23, 59, 60, 106, 115) . Recently, Wegener et al. (115) determined that strains of S. hyicus yielded high MICs (>64.0 ,ug/ml) of sulfadiazine-trimethoprim when tested in Mueller-Hinton broth but were susceptible when tested by the agar disk diffusion method on Mueller-Hinton agar. Even though the Enterococcus faecalis quality control strain yielded MICs within stated parameters, indicating that excessive thymidine levels were not present in the test medium, addition of thymidine phosphorylase to the test medium reduced MICs for S. hyicus to 0.06 ,ug/ml. The authors concluded that S. hyicus is very sensitive to thymidine levels and recommended that S. hyicus ATCC 11249 be included as a quality control strain when S. hyicus strains are tested with sulfonamides. In conclusion, it seems likely that as future performance standards are developed for veterinary pathogens, methodology and quality control guidelines will differ from those used for human pathogens.
A limited number of commercially available and/or automated systems have been evaluated for antimicrobial susceptibility testing of veterinary pathogens. In a recent study (75) , the Sceptor System (Becton Dickinson) was compared with the agar dilution method for testing 136 gram-positive bacterial isolates and 75 fastidious gram-negative isolates. While complete agreement between the methods was 95.7% with the 10 antimicrobial agents tested against the gram-positive isolates, complete agreement was only 88.3% between methods for 8 agents tested against the fastidious gram-negative isolates. Newman et al. (73) compared a commercially available microdilution panel with the disk diffusion method, using 11 antimicrobial agents and 254 veterinary clinical isolates of staphylococci and streptococci. They found a 92.3% agreement between the systems and concluded that the commercial system (Micro-Media Systems, San Jose, Calif.) was a reliable method for testing gram-positive animal isolates. While several other laboratories have used commercially prepared customized microtiter dilution panels, rigorous validation of these systems has not been reported.
Interpretive Criteria
Antimicrobial susceptibility tests should provide results that the clinician can use to increase the potential for a successful therapeutic outcome. Interpretive criteria for categorizing isolates as susceptible or resistant are based on a data base consisting of the MIC of the drug for a bacterial population (under quality-controlled conditions), the pharmacokinetics of the antimicrobial agent in the host species, and the reasonable correlation with the clinical outcome (71, 76, 81, 82) . It is important for the diagnostician to realize that an isolate cannot be categorized as susceptible or resistant unless all of these data for setting the breakpoint have been established. The bacterial population for which MIC data should be obtained should consist of at least 300 clinically relevant isolates (71) . The pharmacokinetic data most relevant to establishing the interpretive criteria are the concentrations of antibacterially active material at the sites of infection. However, the guideline provided by Barry (6), i.e., that the organism is susceptible if inhibited by one-half the mean blood level or one-fourth the peak blood level, is still used with success for setting the MIC breakpoint. Finally, in vitro susceptibility should be correlated VOL. 7, 1994 on October 19, 2017 by guest http://cmr.asm.org/ Downloaded from with therapeutic outcome, with experience suggesting that the correlation should exceed 85% (98) .
In general, these rigorous interpretive criteria have not have been established for all antimicrobial agents used in veterinary medicine. The most frequently used interpretive criteria for categorizing veterinary isolates as susceptible or resistant are those recommended by the NCCLS (12, 62, 63, 74, 78, 82) on the basis of isolates and pharmacokinetic data from humans. Their use for predicting the antimicrobial susceptibility of veterinary pathogens has been questioned (52, 64, 116) . In this regard, the use of AST reports by the veterinary clinician has been characterized, perhaps not altogether facetiously, as "simply a case of the blind leading the blind" (116) .
The paucity of veterinary-specific guidelines has resulted in various recommendations for either performance or interpretation of AST. Burrows (11) has recommended a MIC breakpoint of .2.0 ,ug/ml for erythromycin resistance when P. haemolytica, P. multocida, or H. somnus isolates from bovine respiratory disease are tested. In contrast, current NCCLS guidelines (69) for erythromycin recommend a breakpoint of s0.5 or .8.0 ,ug/ml for categorizing human pathogens as susceptible or resistant, respectively. While it is not surprising that the breakpoint for cattle would be different from that for humans, the recommendation of Burrows (11) was based on the pharmacokinetic data obtained with erythromycin administered at an extra-label dose of 15 mg/kg rather than the approved dose in cattle of 2.2 to 4.4 mg/kg. Libal (61) and Post et al. (78) have suggested that MIC testing is preferable to agar disk diffusion tests to determine the antimicrobial susceptibilities of veterinary pathogens because of the qualitative nature of the latter test method and lack of zone size interpretive criteria available for veterinary pathogens in the different animal species. However, this recommendation suggests that the veterinarian or veterinary diagnostician has access to host-specific pharmacokinetic information upon which to calculate the appropriate breakpoint. Also, differences in the pharmacokinetics of an antimicrobial agent may necessitate the development of different interpretive criteria for various animal species (10, 68, 118) . For example, at a dose of 3 mg/kg administered intramuscularly in both species, the peak concentrations of the cephalosporin antibiotic, ceftiofur, in serum were 16.7 and 2.5 ,ug/ml for pigs and day-old chicks, respectively (68, 118 (74, 86, 87) . Milk contains high levels of protein, fat, and cations, all of which may affect the activity of an antibiotic (86) . The interaction of milk with the antimicrobial agent has prompted several workers to question the validity of standard agar disk diffusion or MIC methods for susceptibility testing of mastitis pathogens (74, 86, 87) . Owens and Watts (74) compared the effect of milk on various antimicrobial agents and determined that milk reduced the activities of novobiocin, streptomycin, gentamicin, tetracycline, and vancomycin. Sandholm et al. (86) compared the activities of various antimicrobial agents against S. aureus, using Iso-Sensitest broth and milk, and determined that the activities of ampicillin, spiramycin, and erythromycin were reduced in milk. Saperstein (87) reported that a commercial system in which milk from infected mammary glands was directly inoculated into a microtiter plate containing dehydrated antimicrobial agents was more appropriate for susceptibility testing of mastitis pathogens than conventional AST methods. However, large-scale inter-and intralaboratory reproducibility studies and quality control guidelines have not been published for this system. All of these authors used current NCCLS guidelines as the basis for their conclusions because these are the only interpretive criteria available. Again, the validity of using these guidelines for mastitis pathogens has not been established, and in one publication the authors (74) suggested that these guidelines be used to compare the results obtained with the two medium types (broth and milk) rather than to predict in vivo efficacy.
In order to develop accurate interpretive guidelines for mastitis therapeutics, MIC breakpoints need to be developed on the basis of MIC data for mastitis pathogens and the concentrations of antimicrobial agent achieved in the mammary gland. Once a MIC breakpoint has been established, in vivo correlations can probably be developed for organisms that are confined to milk, such as S. agalactiae and S. dysgalactiae. Determining the in vivo correlations will be more problematic for S. aureus because these organisms may be sequestered in polymorphonuclear leukocytes or behind scar tissue barriers (74, 86) , which reduces treatment efficacy. By using MIC data, antimicrobial agent levels in milk and in vivo correlations to develop interpretive criteria, factors that affect AST accuracy, can be taken into consideration and appropriate adjustments can be made to the interpretive criteria. Recently, Thornsberry et al. (99) reported the development of MIC breakpoints and agar disk diffusion interpretive criteria for pirlimycin, a new lincosaminide antimicrobial agent, by using MIC data obtained with mastitis pathogens and the concentration of the antimicrobial agent achieved in the mammary gland. CONCLUSIONS Veterinary diagnostic laboratories are under increasing demand to provide rapid, accurate identification of veterinary pathogens with diminishing resources. Additionally, the current regulatory climate to reduce extra-label antimicrobial agent use and avoid antimicrobial residues in food animals has emphasized the need for well-controlled, clinically relevant antimicrobial susceptibility tests for veterinary pathogens. Currently marketed identification systems offer convenience and rapid identification of veterinary pathogens, but the accuracy of the systems varies widely, particularly between pathogens from different host species. In many instances, simply increasing the number of strains and species of veterinary pathogens in the system data base would dramatically improve system accuracy. Ultimately, it is the responsibility of the veterinary microbiologist to determine if a commercial identification system provides acceptable accuracy levels for a given group of organisms. The development of improved performance standards and AST interpretive criteria in veterinary microbiology will take several years. The NCCLS Veterinary Antimicrobial Susceptibility Testing Subcommittee, in cooperation with other professional and regulatory groups, has begun the process of formalizing these standards. As improved standards become available, the veterinary diagnostic microbiologist will then have the tools to provide the veterinarian with more accurate information from which to make informed decisions on the appropriate course of therapy.
